HRT Financial’s Veraxa Biotech AG VRXA Stock Holding History

HRT Financial’s Portfolio VRXA Stock Details VRXA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$35K	Buy	+18,874	New	+$151K	﹤0.01%	3850

Other funds holding VRXA

UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Susquehanna International Group Bala Cynwyd, Pennsylvania $1.28T AUM 58.89% 1-Year Est. Return

PMAM

Picton Mahoney Asset Management Toronto, Ontario, Canada $13.5B AUM 51.46% 1-Year Est. Return

WAM

Wolverine Asset Management Chicago, Illinois $11.4B AUM 5.65% 1-Year Est. Return

JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

CIAM

Caitong International Asset Management Hong Kong $729M AUM 1,176.98% 1-Year Est. Return

HRT Financial's VRXA Position: Q2 2026 in Review

HRT Financial opened a new position in Veraxa Biotech AG (VRXA) in Q2 2026: 18,874 shares worth $35K. The stake represents ﹤0.01% of the portfolio and ranks #3850 among its holdings.

8 funds tracked by Wall St. Rank hold VRXA as of Q2 2026.

HRT Financial held 18,874 shares of Veraxa Biotech AG worth $35K as of Q2 2026.
Veraxa Biotech AG was a new HRT Financial position in Q2 2026.
Veraxa Biotech AG made up ﹤0.01% of HRT Financial's portfolio in Q2 2026, its #3850 holding.
8 funds tracked by Wall St. Rank held Veraxa Biotech AG as of Q2 2026.

Based on HRT Financial's 13F filing for Q2 2026, filed 14 Aug 2026.